Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Burden of atrial fibrillation and poor rate control detected by continuous monitoring and the risk for heart failure hospitalization.

Sarkar S, Koehler J, Crossley GH, Tang WH, Abraham WT, Warman EN, Whellan DJ.

Am Heart J. 2012 Oct;164(4):616-24. doi: 10.1016/j.ahj.2012.06.020.

PMID:
23067922
2.

Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality.

Bunch TJ, Day JD, Olshansky B, Stolen KQ, Mullin CM; INTRINSIC RV Study Investigators.

Heart Rhythm. 2009 Jan;6(1):2-8. doi: 10.1016/j.hrthm.2008.09.025. Epub 2008 Sep 27.

PMID:
18996055
3.

Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics.

Whellan DJ, Sarkar S, Koehler J, Small RS, Boyle A, Warman EN, Abraham WT.

Am J Cardiol. 2013 Jan 1;111(1):79-84. doi: 10.1016/j.amjcard.2012.08.050. Epub 2012 Oct 2.

PMID:
23040596
4.

Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory setting.

Cowie MR, Sarkar S, Koehler J, Whellan DJ, Crossley GH, Tang WH, Abraham WT, Sharma V, Santini M.

Eur Heart J. 2013 Aug;34(31):2472-80. doi: 10.1093/eurheartj/eht083. Epub 2013 Mar 19.

5.

The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality.

Ousdigian KT, Borek PP, Koehler JL, Heywood JT, Ziegler PD, Wilkoff BL.

Circ Arrhythm Electrophysiol. 2014 Jun;7(3):370-6. doi: 10.1161/CIRCEP.113.001212. Epub 2014 May 17.

6.

Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.

Whellan DJ, Ousdigian KT, Al-Khatib SM, Pu W, Sarkar S, Porter CB, Pavri BB, O'Connor CM; PARTNERS Study Investigators.

J Am Coll Cardiol. 2010 Apr 27;55(17):1803-10. doi: 10.1016/j.jacc.2009.11.089.

7.

Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy.

Boriani G, Gasparini M, Landolina M, Lunati M, Proclemer A, Lonardi G, Iacopino S, Rahue W, Biffi M, DiStefano P, Grammatico A, Santini M; ClinicalService cardiac centres.

Eur J Heart Fail. 2011 Aug;13(8):868-76. doi: 10.1093/eurjhf/hfr046. Epub 2011 May 10.

8.

Continuous versus intermittent monitoring of ventricular rate in patients with permanent atrial fibrillation.

Ziegler PD, Koehler JL, Verma A.

Pacing Clin Electrophysiol. 2012 May;35(5):598-604. doi: 10.1111/j.1540-8159.2012.03349.x. Epub 2012 Mar 6.

PMID:
22394432
9.

Heart failure in patients with atrial fibrillation is associated with a high symptom and hospitalization burden: the RealiseAF survey.

Silva-Cardoso J, Zharinov OJ, Ponikowski P, Naditch-Brûlé L, Lewalter T, Brette S, Steg PG; RealiseAF Investigators.

Clin Cardiol. 2013 Dec;36(12):766-74. doi: 10.1002/clc.22209. Epub 2013 Sep 17.

10.

Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trial.

Botto GL, Boriani G, Favale S, Landolina M, Molon G, Tondo C, Biffi M, Grandinetti G, De Filippo P, Raciti G, Padeletti L.

Trials. 2011 Feb 15;12:44. doi: 10.1186/1745-6215-12-44.

11.

The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study.

Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C, Miller C, Qi D, Ziegler PD.

Circ Arrhythm Electrophysiol. 2009 Oct;2(5):474-80. doi: 10.1161/CIRCEP.109.849638. Epub 2009 Aug 4.

12.

Persistent atrial fibrillation worsens heart rate variability, activity and heart rate, as shown by a continuous monitoring by implantable biventricular pacemakers in heart failure patients.

Puglisi A, Gasparini M, Lunati M, Sassara M, Padeletti L, Landolina M, Botto GL, Vincenti A, Bianchi S, Denaro A, Grammatico A, Boriani G; InSync III Italian Registry Investigators.

J Cardiovasc Electrophysiol. 2008 Jul;19(7):693-701. doi: 10.1111/j.1540-8167.2007.01093.x. Epub 2008 Mar 4.

PMID:
18328039
13.

Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention.

Ziegler PD, Glotzer TV, Daoud EG, Singer DE, Ezekowitz MD, Hoyt RH, Koehler JL, Coles J Jr, Wyse DG.

Am J Cardiol. 2012 Nov 1;110(9):1309-14. doi: 10.1016/j.amjcard.2012.06.034. Epub 2012 Jul 20.

PMID:
22819433
14.

Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias.

Saksena S, Hettrick DA, Koehler JL, Grammatico A, Padeletti L.

Am Heart J. 2007 Nov;154(5):884-92. Epub 2007 Sep 14.

PMID:
17967594
15.

Ventricular high-rate episodes in pacemaker diagnostics identify a high-risk subgroup of patients with tachy-brady syndrome.

Willems R, Morck ML, Exner DV, Rose SM, Gillis AM.

Heart Rhythm. 2004 Oct;1(4):414-21.

PMID:
15851193
16.

Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapy.

Caldwell JC, Contractor H, Petkar S, Ali R, Clarke B, Garratt CJ, Neyses L, Mamas MA.

Europace. 2009 Oct;11(10):1295-300. doi: 10.1093/europace/eup201. Epub 2009 Aug 1.

17.

The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients.

Fischer A, Ousdigian KT, Johnson JW, Gillberg JM, Wilkoff BL.

Heart Rhythm. 2012 Jan;9(1):24-31. doi: 10.1016/j.hrthm.2011.08.005. Epub 2011 Aug 9.

PMID:
21835150
18.

Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction.

McManus DD, Hsu G, Sung SH, Saczynski JS, Smith DH, Magid DJ, Gurwitz JH, Goldberg RJ, Go AS; Cardiovascular Research Network PRESERVE Study.

J Am Heart Assoc. 2013 Feb 1;2(1):e005694. doi: 10.1161/JAHA.112.005694.

19.

Stratifying patients at the risk of heart failure hospitalization using existing device diagnostic thresholds.

Sharma V, Rathman LD, Small RS, Whellan DJ, Koehler J, Warman E, Abraham WT.

Heart Lung. 2015 Mar-Apr;44(2):129-36. doi: 10.1016/j.hrtlng.2014.07.007. Epub 2014 Dec 24.

20.

Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population.

Shanmugam N, Boerdlein A, Proff J, Ong P, Valencia O, Maier SK, Bauer WR, Paul V, Sack S.

Europace. 2012 Feb;14(2):230-7. doi: 10.1093/europace/eur293. Epub 2011 Sep 20.

Items per page

Supplemental Content

Write to the Help Desk